Myc-TEAD4 Citations (8)

Originally described in: Structural insights into the YAP and TEAD complex.
Li Z, Zhao B, Wang P, Chen F, Dong Z, Yang H, Guan KL, Xu Y Genes Dev. 2010 Feb 1;24(3):235-40. PubMed Journal

---

Articles Citing Myc-TEAD4

Articles
Aerobic glycolysis tunes YAP/TAZ transcriptional activity. Enzo E, Santinon G, Pocaterra A, Aragona M, Bresolin S, Forcato M, Grifoni D, Pession A, Zanconato F, Guzzo G, Bicciato S, Dupont S. EMBO J. 2015 May 12;34(10):1349-70. doi: 10.15252/embj.201490379. Epub 2015 Mar 21. PubMed
Optimal myelin elongation relies on YAP activation by axonal growth and inhibition by Crb3/Hippo pathway. Fernando RN, Cotter L, Perrin-Tricaud C, Berthelot J, Bartolami S, Pereira JA, Gonzalez S, Suter U, Tricaud N. Nat Commun. 2016 Jul 20;7:12186. doi: 10.1038/ncomms12186. PubMed
Genetic Factors of the Disease Course After Sepsis: Rare Deleterious Variants Are Predictive. Taudien S, Lausser L, Giamarellos-Bourboulis EJ, Sponholz C, Schoneweck F, Felder M, Schirra LR, Schmid F, Gogos C, Groth S, Petersen BS, Franke A, Lieb W, Huse K, Zipfel PF, Kurzai O, Moepps B, Gierschik P, Bauer M, Scherag A, Kestler HA, Platzer M. EBioMedicine. 2016 Oct;12:227-238. doi: 10.1016/j.ebiom.2016.08.037. Epub 2016 Sep 15. PubMed
TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Zhou Y, Huang T, Zhang J, Wong CC, Zhang B, Dong Y, Wu F, Tong JHM, Wu WKK, Cheng ASL, Yu J, Kang W, To KF. Oncogene. 2017 Nov 23;36(47):6518-6530. doi: 10.1038/onc.2017.257. Epub 2017 Jul 31. PubMed
YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis. Pajtler KW, Wei Y, Okonechnikov K, Silva PBG, Vouri M, Zhang L, Brabetz S, Sieber L, Gulley M, Mauermann M, Wedig T, Mack N, Imamura Kawasawa Y, Sharma T, Zuckermann M, Andreiuolo F, Holland E, Maass K, Korkel-Qu H, Liu HK, Sahm F, Capper D, Bunt J, Richards LJ, Jones DTW, Korshunov A, Chavez L, Lichter P, Hoshino M, Pfister SM, Kool M, Li W, Kawauchi D. Nat Commun. 2019 Sep 2;10(1):3914. doi: 10.1038/s41467-019-11884-5. PubMed
YAP induces an oncogenic transcriptional program through TET1-mediated epigenetic remodeling in liver growth and tumorigenesis. Wu BK, Mei SC, Chen EH, Zheng Y, Pan D. Nat Genet. 2022 Aug;54(8):1202-1213. doi: 10.1038/s41588-022-01119-7. Epub 2022 Jul 14. PubMed
Covalent disruptor of YAP-TEAD association suppresses defective Hippo signaling. Fan M, Lu W, Che J, Kwiatkowski NP, Gao Y, Seo HS, Ficarro SB, Gokhale PC, Liu Y, Geffken EA, Lakhani J, Song K, Kuljanin M, Ji W, Jiang J, He Z, Tse J, Boghossian AS, Rees MG, Ronan MM, Roth JA, Mancias JD, Marto JA, Dhe-Paganon S, Zhang T, Gray NS. Elife. 2022 Oct 27;11:e78810. doi: 10.7554/eLife.78810. PubMed
Structure-based discovery of a novel small-molecule inhibitor of TEAD palmitoylation with anticancer activity. Gridnev A, Maity S, Misra JR. Front Oncol. 2022 Nov 29;12:1021823. doi: 10.3389/fonc.2022.1021823. eCollection 2022. PubMed

If you have published an article using this material, please email us at to have your article added to this page.